Nuwellis Inc (FRA:22S1)

Q3 2025 Nuwellis Inc Earnings Call Transcript

Nov 12, 2025 / 02:00 PM GMT

Release Date Price: €6554.73

Transcript 10-Q8-K

Key Points

Positve

Nuwellis Inc (NUWE) reported a 23% increase in consumables utilization and a fourfold increase in US console sales sequentially from the second quarter.
The company introduced a new 24-hour aqueduct circuit for hospital-based outpatient use, providing flexibility and consistency in therapy.
Nuwellis Inc (NUWE) achieved a milestone with the first Aquadex therapy delivered in a hospital-based outpatient setting under a new CMS reimbursement code.
The company is advancing its pediatric CRRT system, Vivian, with new US patent allowances, demonstrating commitment to innovation in pediatric fluid management.
Nuwellis Inc (NUWE) completed two successful capital raises, providing financial flexibility to support its US revenue growth strategy into 2026.

Negative

Total revenue for the third quarter decreased by 6% compared to the third quarter of 2024, primarily due to one-time prior year sales and a decrease in international revenues.
Gross margin declined to 65.2% from 70% in Q3 2024, mainly due to under absorption of fixed overhead from lower production volumes earlier in the year.
Selling, general, and administrative expenses increased to $3.5 million from $2.7 million in the same period last year, reflecting increased payroll and compensation expenses.
Research and development expenses rose to $603,000 from $486,000 last year, driven by increased investment in sustained engineering and air quality systems.
Operating loss for the quarter was $2.7 million, compared to an operating loss of $1.5 million in Q3 2024, indicating increased financial pressure.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NUWE.OQ - Nuwellis Inc
Q3 2025 Nuwellis Inc Earnings Call
Nov 12, 2025 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Please stand by. Your program is about to begin. If you require assistance throughout the event today, please press 0.

Good day everyone and welcome to today's Noelli 3rd quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. Later you may have the opportunity to ask questions during the question-and-answer session.

Please note today's call will be recorded and I will be standing by should you need any assistance. It is now my pleasure to turn the conference over to Leah McMullen, director of communications. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.